RNS Number : 4832I
Kropz PLC
17 October 2024
 

 17 October 2024

 

Kropz plc

 

("Kropz" or the "Company")

 

Admission of Fundraising Shares
and
Total Voting Rights

 

Kropz plc (AIM: KRPZ), an emerging African phosphate producer, announces that the 643,873,018 new Ordinary Shares ("New Ordinary Shares") to be issued pursuant to the Fundraising will be admitted to trading on AIM ("Admission") and dealings in respect of the New Ordinary Shares will commence at 8.00 a.m. on 18 October 2024.

 

Following Admission, the Company's issued share capital will be 1,567,591,241 Ordinary Shares. This figure of 1,567,591,241 may then be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information visit www.kropz.com or contact:

 

Kropz Plc 

Via Tavistock 

Louis Loubser (CEO) 

+44 (0) 207 920 3150 



Grant Thornton UK LLP 

Nominated Adviser 

Samantha Harrison 

Harrison Clarke 

Ciara Donnelly 

+44 (0) 20 7383 5100 



Hannam & Partners 

Broker 

Andrew Chubb 

Ernest Bell 

+44 (0) 20 7907 8500 



Tavistock 

Financial PR & IR (UK) 

Nick Elwes 

Jos Simson 

 

+44 (0) 207 920 3150 

kropz@tavistock.co.uk 



R&A Strategic Communications 

PR (South Africa) 

Charmane Russell 

Marion Brower 

+27 (0) 11 880 3924 

charmane@rasc.co.za  

marion@rasc.co.za 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKABNPBDDOKD